share_log

Zevra Therapeutics Says Arimoclomol Research Featured In Two Poster Presentations At 19th Annual WORLDSymposium 2023

Zevra Therapeutics Says Arimoclomol Research Featured In Two Poster Presentations At 19th Annual WORLDSymposium 2023

Zevra Therapeutics 表示,Arimoclomol 的研究出现在2023年第 19 届年度世界研讨会的两份海报展示中
Benzinga ·  2023/02/24 07:37

Interim data analysis of four-year, open-label extension from Phase 2/3 clinical trial suggests arimoclomol may reduce long-term progression of Niemann-Pick Disease Type C (NPC)

2/3期临床试验四年开放标签延期的中期数据分析表明,阿利莫洛尔可能会减缓C型尼曼-皮克病(NPC)的长期进展

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发